A Phase 1/2a to Evaluate the Safety and Efficacy of Adipose Tissue Allograft (BRC-OA) in Patients With Osteoarthritis of the Knee

Recruiting

Phase 1

Phase 2

BRC-OAA Phase 1/2a to Evaluate the Safety and Efficacy of Adipose Tissue Allograft (BRC-OA) in Patients With Osteoarthritis of the Knee

Sponsor:

Britecyte

Code:

NCT06828666

Conditions

Osteoarthritis of Knee

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Cryopreserved Devitalized Adipose Tissue Allograft

Normal Saline (Placebo)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-01-21. This information was provided to ClinicalTrials.gov by Britecyte on 2025-11-03.